RCT: Oral contezolid vs. linezolid in adults with complicated skin and soft tissue infections.

A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections – Journal of Antimicrobial Therapy (link to abstract – $ for full-text)

Commentary on Twitter

Phase III efficacy & safety of oral contezolid Vs linezolid in adults with c.SSTIs
?Non inferior
?Interestingly:Contezolid demonstrated significant lower incidence thrombocytopenia (0% Wow vs 2.3%) & leucopenia (0.3% vs 3.4%) than linezolid
?QIDP https://t.co/wSvxUInnkZ

— Antibiotic Steward Bassam Ghanem (@ABsteward) March 11, 2022